PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson’s Disease

2019 ◽  
Vol 40 (3) ◽  
pp. 357-367
Author(s):  
Jaya Sanyal ◽  
Athira Anirudhan ◽  
Tapas Kumar Banerjee ◽  
Gautam Guha ◽  
Ramakrishnan Veerabathiran ◽  
...  
2018 ◽  
Vol 137 (5) ◽  
pp. 509-514 ◽  
Author(s):  
C. J. Mao ◽  
Y. T. Xiong ◽  
F. Wang ◽  
Y. P. Yang ◽  
W. Yuan ◽  
...  

2008 ◽  
Vol 66 (1) ◽  
pp. 22-25 ◽  
Author(s):  
Carlos Juri ◽  
Paola Viviani ◽  
Pedro Chaná

Parkinson's disease (PD) is a neurodegenerative disorder, predominantly characterized by the presence of motor symptoms. However, the non motor manifestations (NMM) are a frequent complaint in the PD patients. There is a lack of information about the risk factors associated with the NMM in these patients. The aim of this study is to evaluate the prevalence of the more common NMM in a population of PD patients and to determine the features associated with its development. We studied 124 ambulatory PD patients. NMM were defined by the presence of neuropsychiatric manifestations, cognitive disorder, autonomic dysfunction or sleep related problems. In a multivariate analysis we found that the years of evolution of the PD and the presence of cognitive dysfunction are the risk factors for the neuropsychiatric and autonomic manifestations, whereas axial impairment is a risk factor for cognitive disorders and dyskinesias is for sleep related problems. In conclusion, this study shows that the features related to the PD progression appear as the main risk factors associated with NMM.


2019 ◽  
Author(s):  
Shuqi Huang ◽  
Nannan Li ◽  
Shuangyan Tu ◽  
Xiaoyi Sun ◽  
Pingqiao Yuan ◽  
...  

Abstract Background Falling is a common and devastating problem in Parkinson’s disease (PD) patients. However, the factors associated with fall among Chinese PD population remain unclear. Aim The aim of this study was to explore the prevalence and potential factors independently contribute to falls in patients with PD. Methods This cross-sectional study recruited one hundred and ninety-seven PD patients from West China Hospital. According to patients or their caregivers’ memory divided them into two different groups: fallers and non-fallers. Demographical information, clinical features and pharmacological conditions of patients were all collected. Results Out of 197 patients (mean age 63.2±9.0 years) 55.3% (110/197) patients had at least one fall in the half of year. Factors associated with falls in PD including: sex, age, co-disease condition, clinical symptoms, the severity of disease, doing activities, the function of balance, cognition, and the emotional conditions. Furthermore, statistically significant differences were found by binary regression in Hoehn and Yahr (H-Y) stage (OR = 11.500, 95% CI = 2.801-47.214, P = 0.001), the Hamilton Depression (HAMD-24) Rating Scale (OR = 1.296, 95% CI = 1.034-1.296, P = 0.011) and the Falls Efficacy (FES) Scale (OR = 1.028, 95% CI = 1.004-1.053, P = 0.021). However, doing exercise (OR = 0.159, 95% CI = 0.046-0.555, P = 0.004) is a protective factor for PD patients. Conclusions Patients with severe disease, bad psychological condition will increase the risk of falling. Monitoring disease progress and pay more attention on non-motor symptoms are needed while patients in the mild stage.


2021 ◽  
Vol 22 (8) ◽  
pp. 4286
Author(s):  
Melania Melis ◽  
Antje Haehner ◽  
Mariano Mastinu ◽  
Thomas Hummel ◽  
Iole Tomassini Tomassini Barbarossa

Deficits in olfaction and taste are among the most frequent non-motor manifestations in Parkinson’s disease (PD) that start very early and frequently precede the PD motor symptoms. The limited data available suggest that the basis of the olfactory and gustatory dysfunction related to PD are likely multifactorial and may include the same determinants responsible for other non-motor symptoms of PD. This review describes the most relevant molecular and genetic factors involved in the PD-related smell and taste impairments, and their associations with the microbiota, which also may represent risk factors associated with the disease.


2012 ◽  
Vol 153 (52) ◽  
pp. 2060-2069 ◽  
Author(s):  
András Guseo

Parkinson’s disease is one of the most frequent progressive degenerative disorders with unknown origin of the nervous system. The commutation of the disease on Guam led to the discovery of a neurotoxin which was also found in other continents. This neurotoxin was identified in the common cyanobacteria (blue-green algae). Early clinical observations suggested some loose correlations with gastric and duodenal ulcer and Parkinson’s disease, while recent studies revealed a toxin, almost identical to that found in cyanobacteria in one strain of Helicobacter pylori, which proved to cause Parkinson like symptoms in animals. Therefore, it cannot be ruled out that there is a slowly progressive poisoning in Parkinson’s disease. The disease specific alpha-sinuclein inclusions can be found in nerve cells of the intestinal mucosa far before the appearance of clinical symptoms indicating that the disease may start in the intestines. These results are strengthened by the results of Borody’s fecal transplants, after which in Parkinson patients showed a symptomatic improvement. Based on these observations the Parkinson puzzle is getting complete. Although these observations are not evidence based, they may indicate a new way for basic clinical research, as well as a new way of thinking for clinicians. These new observations in psycho-neuro-immunology strengthen the fact that immunological factors may also play a critical factor facilitating local cell necrosis which may be influenced easily. Orv. Hetil., 2012, 153, 2060–2069.


2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Muhammad Aslam ◽  
Nirosiya Kandasamy ◽  
Anwar Ullah ◽  
Nagarajan Paramasivam ◽  
Mehmet Ali Öztürk ◽  
...  

AbstractRare variants in the beta-glucocerebrosidase gene (GBA1) are common genetic risk factors for alpha synucleinopathy, which often manifests clinically as GBA-associated Parkinson’s disease (GBA-PD). Clinically, GBA-PD closely mimics idiopathic PD, but it may present at a younger age and often aggregates in families. Most carriers of GBA variants are, however, asymptomatic. Moreover, symptomatic PD patients without GBA variant have been reported in families with seemingly GBA-PD. These observations obscure the link between GBA variants and PD pathogenesis and point towards a role for unidentified additional genetic and/or environmental risk factors or second hits in GBA-PD. In this study, we explored whether rare genetic variants may be additional risk factors for PD in two families segregating the PD-associated GBA1 variants c.115+1G>A (ClinVar ID: 93445) and p.L444P (ClinVar ID: 4288). Our analysis identified rare genetic variants of the HSP70 co-chaperone DnaJ homolog subfamily B member 6 (DNAJB6) and lysosomal protein prosaposin (PSAP) as additional factors possibly influencing PD risk in the two families. In comparison to the wild-type proteins, variant DNAJB6 and PSAP proteins show altered functions in the context of cellular alpha-synuclein homeostasis when expressed in reporter cells. Furthermore, the segregation pattern of the rare variants in the genes encoding DNAJB6 and PSAP indicated a possible association with PD in the respective families. The occurrence of second hits or additional PD cosegregating rare variants has important implications for genetic counseling in PD families with GBA1 variant carriers and for the selection of PD patients for GBA targeted treatments.


Author(s):  
Kristina Rosqvist ◽  
Per Odin ◽  
Stefan Lorenzl ◽  
Wassilios G. Meissner ◽  
Bastiaan R. Bloem ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document